Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib and Chemotherapy in Neoadjuvant Breast Cancer
NCT00135018Phase 2Completed
- Sponsor
- Organisation for Oncology and Translational Research
- Start
- Feb 2006
- Primary completion
- Dec 2011
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of celecoxib in Invasive breast cancer (IBC), sponsored by Organisation for Oncology and Translational Research. Started Feb 2006; status: completed.
02
Drugs
celecoxib
03
Conditions
Invasive breast cancer (IBC)
Beyond the preview
Go deeper on NCT00135018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00135018.